| 15.3 |
46.0 |
GO:2000111 |
cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
| 12.5 |
50.2 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 9.8 |
29.3 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 7.7 |
54.0 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 7.4 |
29.4 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 6.9 |
20.8 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 6.4 |
25.6 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 6.3 |
18.8 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 6.1 |
18.4 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 6.0 |
17.9 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 5.9 |
17.8 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 5.5 |
16.4 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 5.2 |
31.3 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 5.1 |
10.2 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 5.1 |
25.3 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 4.9 |
14.7 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 4.9 |
14.7 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 4.7 |
84.5 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 4.6 |
9.3 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 4.6 |
32.4 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 4.3 |
12.9 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
| 4.3 |
12.8 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 4.2 |
42.4 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 4.2 |
16.7 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 4.1 |
12.2 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 4.0 |
12.1 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 4.0 |
28.1 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 4.0 |
12.0 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 3.9 |
15.6 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 3.9 |
11.6 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 3.8 |
15.3 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 3.7 |
11.2 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 3.7 |
11.1 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 3.4 |
10.2 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 3.4 |
27.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 3.4 |
27.2 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 3.3 |
29.7 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 3.3 |
3.3 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 3.2 |
22.7 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 3.2 |
12.9 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 3.2 |
22.6 |
GO:2000662 |
interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
| 3.1 |
6.1 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 2.9 |
8.8 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 2.9 |
31.9 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 2.9 |
11.6 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 2.9 |
31.4 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 2.8 |
8.5 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 2.8 |
42.0 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 2.8 |
8.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 2.8 |
8.4 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 2.7 |
13.6 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 2.7 |
13.4 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 2.7 |
18.8 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 2.6 |
7.9 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 2.6 |
15.3 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 2.5 |
19.8 |
GO:0014848 |
urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 2.5 |
29.4 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 2.4 |
12.2 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 2.4 |
12.0 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 2.3 |
16.4 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 2.3 |
32.8 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 2.3 |
7.0 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 2.3 |
4.7 |
GO:0032910 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
| 2.3 |
7.0 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 2.2 |
6.7 |
GO:0051464 |
positive regulation of cortisol secretion(GO:0051464) |
| 2.2 |
11.1 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 2.2 |
2.2 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 2.2 |
6.7 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 2.2 |
10.8 |
GO:0032276 |
regulation of gonadotropin secretion(GO:0032276) |
| 2.2 |
4.3 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 2.2 |
21.6 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 2.1 |
2.1 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 2.1 |
6.2 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 2.0 |
6.1 |
GO:0010752 |
signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) |
| 2.0 |
42.7 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 2.0 |
6.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 2.0 |
44.0 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 2.0 |
5.9 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 1.9 |
5.8 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.9 |
9.7 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 1.9 |
3.9 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 1.8 |
5.5 |
GO:0046959 |
habituation(GO:0046959) |
| 1.8 |
7.3 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.8 |
31.1 |
GO:0001553 |
luteinization(GO:0001553) |
| 1.8 |
7.2 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) ATP transport(GO:0015867) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 1.8 |
10.8 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.8 |
3.6 |
GO:2000347 |
positive regulation of hepatocyte proliferation(GO:2000347) |
| 1.8 |
5.3 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 1.8 |
3.5 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 1.8 |
5.3 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.7 |
5.2 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 1.7 |
13.9 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 1.7 |
5.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 1.7 |
8.5 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.7 |
19.9 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.6 |
26.1 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 1.6 |
6.5 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 1.6 |
8.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 1.6 |
12.9 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 1.6 |
27.2 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.6 |
15.9 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 1.6 |
4.8 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 1.6 |
12.6 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 1.6 |
6.3 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.6 |
4.7 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 1.6 |
10.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.5 |
6.2 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) peptidyl-aspartic acid modification(GO:0018197) |
| 1.5 |
17.0 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 1.5 |
1.5 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 1.5 |
6.1 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
| 1.5 |
4.6 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.5 |
24.1 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 1.5 |
1.5 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 1.5 |
8.9 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 1.5 |
16.3 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 1.4 |
5.7 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 1.4 |
11.3 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 1.4 |
8.5 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 1.4 |
8.1 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 1.3 |
5.4 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 1.3 |
5.3 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 1.3 |
20.9 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 1.3 |
12.9 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 1.3 |
3.9 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 1.3 |
2.6 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 1.3 |
50.0 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 1.3 |
3.8 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.3 |
8.9 |
GO:0015862 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 1.3 |
3.8 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 1.2 |
5.0 |
GO:0045687 |
positive regulation of glial cell differentiation(GO:0045687) |
| 1.2 |
6.2 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 1.2 |
3.7 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 1.2 |
2.4 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 1.2 |
9.7 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 1.2 |
21.8 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 1.2 |
9.7 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 1.2 |
1.2 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 1.2 |
6.0 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 1.2 |
10.7 |
GO:0045056 |
transcytosis(GO:0045056) |
| 1.2 |
3.6 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
| 1.2 |
47.4 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 1.2 |
3.5 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.2 |
4.6 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 1.2 |
4.6 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 1.1 |
4.6 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 1.1 |
1.1 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 1.1 |
13.7 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 1.1 |
13.7 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 1.1 |
14.7 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 1.1 |
12.4 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 1.1 |
14.6 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 1.1 |
19.0 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 1.1 |
5.5 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 1.1 |
6.6 |
GO:0071361 |
autophagic cell death(GO:0048102) cellular response to ethanol(GO:0071361) |
| 1.1 |
3.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 1.1 |
12.0 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 1.1 |
3.3 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 1.1 |
7.6 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
| 1.1 |
7.6 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 1.1 |
11.9 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 1.1 |
2.1 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 1.1 |
2.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 1.1 |
2.1 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 1.0 |
7.3 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 1.0 |
3.1 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 1.0 |
23.9 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 1.0 |
1.0 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 1.0 |
4.1 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.0 |
41.2 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 1.0 |
5.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 1.0 |
8.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 1.0 |
15.1 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 1.0 |
8.0 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 1.0 |
4.0 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 1.0 |
2.0 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 1.0 |
2.0 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 1.0 |
51.1 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 1.0 |
3.9 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of receptor catabolic process(GO:2000645) |
| 1.0 |
2.9 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 1.0 |
3.9 |
GO:2000544 |
cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 1.0 |
10.7 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 1.0 |
9.6 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 1.0 |
5.7 |
GO:0031103 |
axon regeneration(GO:0031103) |
| 0.9 |
5.6 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 0.9 |
2.8 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.9 |
8.4 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.9 |
11.9 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.9 |
6.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.9 |
6.4 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.9 |
13.6 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.9 |
23.3 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.9 |
5.3 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.9 |
8.0 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.9 |
6.2 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.9 |
12.3 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.9 |
4.3 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.9 |
1.7 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) regulation of cardiac cell fate specification(GO:2000043) |
| 0.9 |
14.5 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.8 |
4.2 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.8 |
22.7 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.8 |
3.4 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
| 0.8 |
5.8 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.8 |
5.8 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.8 |
10.6 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.8 |
11.4 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.8 |
2.4 |
GO:0009182 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.8 |
2.4 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.8 |
4.8 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.8 |
9.5 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.8 |
3.9 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.8 |
4.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.8 |
5.5 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.8 |
2.3 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.8 |
2.3 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.8 |
3.1 |
GO:2000392 |
regulation of lamellipodium morphogenesis(GO:2000392) positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.8 |
1.5 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.8 |
4.6 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.8 |
4.6 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.8 |
7.6 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.8 |
3.0 |
GO:2000258 |
negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.8 |
7.5 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.8 |
5.3 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.7 |
2.2 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.7 |
1.5 |
GO:0002323 |
natural killer cell activation involved in immune response(GO:0002323) |
| 0.7 |
3.7 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.7 |
2.2 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 0.7 |
2.2 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.7 |
4.4 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.7 |
1.4 |
GO:0010523 |
negative regulation of calcium ion transport into cytosol(GO:0010523) |
| 0.7 |
0.7 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.7 |
1.4 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.7 |
4.3 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.7 |
2.9 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.7 |
2.1 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.7 |
4.2 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.7 |
0.7 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.7 |
2.8 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.7 |
1.4 |
GO:0045188 |
regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.7 |
4.9 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.7 |
26.4 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.7 |
3.5 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.7 |
2.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.7 |
6.1 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.7 |
4.7 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.7 |
3.3 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.7 |
2.0 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.7 |
2.0 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.7 |
2.0 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.7 |
2.0 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.6 |
13.0 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.6 |
1.3 |
GO:0070944 |
neutrophil mediated killing of bacterium(GO:0070944) |
| 0.6 |
1.9 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.6 |
3.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.6 |
15.8 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.6 |
3.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
| 0.6 |
1.9 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.6 |
1.9 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.6 |
1.2 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.6 |
3.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.6 |
10.4 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.6 |
2.4 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.6 |
4.3 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.6 |
2.4 |
GO:0060043 |
regulation of cardiac muscle cell proliferation(GO:0060043) |
| 0.6 |
19.1 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.6 |
13.1 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.6 |
1.2 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.6 |
1.2 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.6 |
8.2 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.6 |
2.3 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.6 |
0.6 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.6 |
4.0 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.6 |
1.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
2.8 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.6 |
4.5 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.6 |
2.8 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.6 |
2.8 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.6 |
7.8 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.6 |
5.0 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.5 |
2.2 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.5 |
4.3 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.5 |
5.4 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.5 |
6.5 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.5 |
1.6 |
GO:0060368 |
regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.5 |
18.7 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.5 |
43.8 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
| 0.5 |
2.1 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.5 |
2.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.5 |
2.1 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.5 |
6.3 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.5 |
1.6 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.5 |
2.1 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.5 |
2.1 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.5 |
3.1 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.5 |
2.6 |
GO:0002793 |
positive regulation of peptide secretion(GO:0002793) |
| 0.5 |
4.1 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.5 |
1.0 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.5 |
2.0 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.5 |
5.5 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.5 |
3.0 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.5 |
1.0 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.5 |
2.5 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.5 |
1.5 |
GO:0009838 |
abscission(GO:0009838) |
| 0.5 |
1.5 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.5 |
2.4 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.5 |
9.0 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.5 |
7.1 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.5 |
1.4 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.5 |
3.3 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.5 |
1.9 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.5 |
5.1 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.5 |
3.3 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.5 |
0.9 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.5 |
1.8 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.5 |
1.4 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.5 |
4.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.5 |
6.8 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.5 |
7.7 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.4 |
6.6 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.4 |
11.9 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.4 |
6.6 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.4 |
1.3 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.4 |
0.9 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.4 |
2.6 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.4 |
11.6 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.4 |
0.9 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.4 |
4.3 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.4 |
3.0 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.4 |
8.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.4 |
2.1 |
GO:0015846 |
polyamine transport(GO:0015846) |
| 0.4 |
7.2 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.4 |
1.7 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.4 |
1.7 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.4 |
2.5 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.4 |
0.8 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.4 |
8.0 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.4 |
4.6 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.4 |
9.1 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.4 |
2.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.4 |
15.7 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.4 |
0.8 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.4 |
1.6 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.4 |
1.6 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.4 |
1.6 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.4 |
10.5 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.4 |
26.6 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.4 |
1.2 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.4 |
4.0 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.4 |
0.8 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
| 0.4 |
23.9 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.4 |
6.4 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.4 |
5.6 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.4 |
1.6 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.4 |
8.7 |
GO:0098927 |
vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.4 |
1.2 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.4 |
0.8 |
GO:2001180 |
negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.4 |
2.0 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.4 |
2.4 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.4 |
5.1 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.4 |
2.0 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.4 |
2.0 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.4 |
7.0 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.4 |
0.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.4 |
5.4 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.4 |
4.2 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.4 |
10.7 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.4 |
2.7 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.4 |
1.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 |
2.3 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.4 |
37.6 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.4 |
8.9 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.4 |
5.9 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.4 |
2.6 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.4 |
15.2 |
GO:0006040 |
amino sugar metabolic process(GO:0006040) |
| 0.4 |
5.4 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.4 |
6.4 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.4 |
3.2 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.4 |
1.1 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.4 |
29.6 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.4 |
1.8 |
GO:0003214 |
cardiac left ventricle morphogenesis(GO:0003214) |
| 0.4 |
2.8 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.3 |
2.1 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.3 |
18.4 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.3 |
2.1 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.3 |
1.0 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.3 |
3.4 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.3 |
4.1 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 |
4.1 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.3 |
1.3 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.3 |
3.0 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.3 |
1.3 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.3 |
0.3 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.3 |
0.7 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.3 |
1.0 |
GO:1901740 |
negative regulation of myoblast fusion(GO:1901740) |
| 0.3 |
1.0 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.3 |
4.3 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.3 |
5.3 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.3 |
1.6 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 |
3.6 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.3 |
1.3 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.3 |
1.9 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.3 |
0.6 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.3 |
7.7 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.3 |
20.8 |
GO:0007613 |
memory(GO:0007613) |
| 0.3 |
1.0 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.3 |
7.3 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.3 |
2.5 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.3 |
6.8 |
GO:0046854 |
lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
| 0.3 |
4.9 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.3 |
4.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.3 |
6.0 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.3 |
1.5 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.3 |
2.1 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.3 |
33.0 |
GO:0050890 |
cognition(GO:0050890) |
| 0.3 |
4.1 |
GO:0061178 |
regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.3 |
0.9 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.3 |
1.4 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.3 |
1.6 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.3 |
4.7 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) |
| 0.3 |
1.6 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.3 |
1.1 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.3 |
1.1 |
GO:0048557 |
embryonic digestive tract morphogenesis(GO:0048557) |
| 0.3 |
2.9 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.3 |
1.3 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.3 |
1.0 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.3 |
3.6 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.3 |
1.0 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.3 |
0.8 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 |
0.8 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.3 |
0.5 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.2 |
7.5 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.2 |
0.2 |
GO:0071404 |
response to low-density lipoprotein particle(GO:0055098) cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.2 |
0.5 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.2 |
1.2 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.2 |
3.8 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.2 |
2.1 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.2 |
14.4 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.2 |
1.8 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
2.9 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.2 |
0.9 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.2 |
0.9 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.2 |
3.6 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 |
1.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.2 |
7.7 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.2 |
1.2 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.2 |
0.6 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.2 |
1.2 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.2 |
0.4 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.2 |
6.1 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.2 |
1.0 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
2.4 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 |
3.7 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.2 |
0.8 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.2 |
2.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
2.3 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.2 |
1.7 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 |
0.8 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
3.6 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.2 |
0.6 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.2 |
2.1 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.2 |
1.5 |
GO:0033151 |
V(D)J recombination(GO:0033151) |
| 0.2 |
6.7 |
GO:0097202 |
activation of cysteine-type endopeptidase activity(GO:0097202) |
| 0.2 |
0.2 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.2 |
2.0 |
GO:0006656 |
phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.2 |
2.7 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
1.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
10.5 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) |
| 0.2 |
3.5 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.2 |
2.7 |
GO:0046621 |
negative regulation of organ growth(GO:0046621) |
| 0.2 |
0.5 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.2 |
1.3 |
GO:1901028 |
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
| 0.2 |
1.3 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.2 |
0.5 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 |
2.6 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.2 |
1.1 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.2 |
0.9 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.2 |
1.8 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.2 |
4.3 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.2 |
0.5 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 |
1.1 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 |
4.1 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
0.6 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.1 |
1.3 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
2.0 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
1.0 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.6 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.1 |
0.4 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
2.3 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.1 |
4.2 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.1 |
0.8 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
1.1 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.1 |
0.7 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 0.1 |
2.5 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.1 |
1.3 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
5.6 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.8 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.1 |
0.9 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 |
0.5 |
GO:0031577 |
spindle checkpoint(GO:0031577) |
| 0.1 |
2.9 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.1 |
0.4 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
1.3 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
0.5 |
GO:0010561 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.1 |
0.6 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.5 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.1 |
2.4 |
GO:0048015 |
phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
| 0.1 |
1.4 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.1 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 |
1.2 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.1 |
2.5 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 |
1.5 |
GO:0032402 |
establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
| 0.1 |
1.3 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.3 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.1 |
0.7 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
2.3 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 |
0.5 |
GO:0036093 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.1 |
1.6 |
GO:0045471 |
response to ethanol(GO:0045471) |
| 0.1 |
2.5 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.3 |
GO:0032799 |
low-density lipoprotein receptor particle metabolic process(GO:0032799) low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.1 |
0.8 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.1 |
3.9 |
GO:0035304 |
regulation of protein dephosphorylation(GO:0035304) |
| 0.1 |
1.5 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.1 |
0.7 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.1 |
1.4 |
GO:0007031 |
peroxisome organization(GO:0007031) |
| 0.1 |
0.6 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.6 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
0.8 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
0.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.5 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.5 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.2 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
9.2 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 |
0.2 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.9 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 |
0.4 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.5 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
3.3 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
| 0.1 |
0.3 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 |
0.2 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
0.9 |
GO:0019363 |
pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.1 |
1.1 |
GO:0051180 |
vitamin transport(GO:0051180) |
| 0.1 |
0.3 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
1.2 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.1 |
0.7 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.1 |
0.2 |
GO:0032612 |
interleukin-1 beta production(GO:0032611) interleukin-1 production(GO:0032612) |
| 0.1 |
0.3 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.2 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.1 |
0.3 |
GO:0050926 |
regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) |
| 0.1 |
0.5 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.4 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.3 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.7 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.3 |
GO:1902475 |
L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.0 |
0.5 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
1.9 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.2 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 |
0.3 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.0 |
0.1 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.0 |
0.2 |
GO:0002861 |
regulation of inflammatory response to antigenic stimulus(GO:0002861) |
| 0.0 |
0.4 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.5 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 |
0.2 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.2 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.0 |
0.5 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.3 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.2 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.4 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.0 |
0.0 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
0.7 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
2.1 |
GO:0006470 |
protein dephosphorylation(GO:0006470) |
| 0.0 |
0.3 |
GO:0030811 |
regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
| 0.0 |
0.1 |
GO:0035773 |
insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 0.0 |
0.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
0.4 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
